Mexiletine for treating myotonia in adults with non-dystrophic myotonic disorders ID1488: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 05 March 2021.
Search results
6 results
-
-
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [ID2727]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 05 March 2021.
-
Sapropterin for treating phenylketonuria [ID1475]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 18 March 2021.
-
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs [ID1658]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 25 March 2021.
-
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy [ID1602]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 26 March 2021.
-
Olaparib for previously treated, hormone-relapsed metastatic prostate cancer with homologous recombination repair gene mutations [ID1640]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 26 March 2021.